HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc S Ernstoff Selected Research

aldesleukin (Proleukin)

2/2015The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.
8/2009Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.
6/2007Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc S Ernstoff Research Topics

Disease

73Neoplasms (Cancer)
11/2021 - 05/2002
53Melanoma (Melanoma, Malignant)
01/2022 - 03/2002
25Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 09/2002
10Neoplasm Metastasis (Metastasis)
08/2018 - 03/2002
7Brain Neoplasms (Brain Tumor)
12/2021 - 10/2008
6Colitis
12/2021 - 05/2012
6Disease Progression
12/2021 - 05/2006
5Glioblastoma (Glioblastoma Multiforme)
03/2017 - 04/2011
4Exanthema (Rash)
09/2019 - 03/2010
4Carcinoma (Carcinomatosis)
10/2018 - 04/2003
4Prostatic Neoplasms (Prostate Cancer)
03/2013 - 05/2006
3Cardiotoxicity
12/2021 - 10/2018
3Diarrhea
11/2021 - 12/2010
3Inflammation (Inflammations)
01/2021 - 01/2012
3Fatigue
11/2018 - 03/2010
3Kidney Neoplasms (Kidney Cancer)
06/2007 - 09/2006
3Leukemia
09/2006 - 04/2003
2Hypophysitis
12/2021 - 11/2016
2Neurologic Manifestations (Neurological Manifestations)
11/2021 - 08/2018
2Vitiligo
01/2021 - 05/2011
2Myocarditis (Carditis)
01/2021 - 01/2019
2Body Weight (Weight, Body)
08/2018 - 05/2015
2Colorectal Neoplasms (Colorectal Cancer)
05/2018 - 11/2010
2Nevus (Nevi)
12/2016 - 09/2002
2Human Influenza (Influenza)
11/2008 - 05/2003
1cell-associated neurotoxicity
12/2021
1Cytokine Release Syndrome
12/2021
1Meningioma (Meningiomas)
11/2021
1Atrioventricular Block
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021

Drug/Important Bio-Agent (IBA)

22Interleukin-2 (IL2)IBA
01/2020 - 01/2003
15CytokinesIBA
11/2018 - 04/2003
13Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
12VaccinesIBA
12/2020 - 03/2004
10NivolumabIBA
12/2021 - 05/2015
9IpilimumabIBA
12/2021 - 05/2012
8Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2006
7Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2006
7Peptides (Polypeptides)IBA
12/2015 - 05/2003
6pembrolizumabIBA
01/2021 - 05/2018
6AntigensIBA
10/2020 - 04/2003
5Temozolomide (Temodar)FDA LinkGeneric
03/2017 - 10/2008
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2015 - 04/2003
5InterferonsIBA
01/2012 - 03/2004
4VemurafenibIBA
11/2020 - 04/2014
4LigandsIBA
10/2020 - 01/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2017 - 02/2009
4Sorafenib (BAY 43-9006)FDA Link
01/2014 - 03/2007
4Pharmaceutical PreparationsIBA
05/2012 - 12/2006
3Alanine Transaminase (SGPT)IBA
12/2021 - 11/2016
3MicroRNAs (MicroRNA)IBA
03/2019 - 01/2018
3Sunitinib (Sutent)FDA Link
03/2019 - 12/2011
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2015 - 01/2006
3aldesleukin (Proleukin)FDA Link
02/2015 - 06/2007
3Cancer VaccinesIBA
03/2008 - 03/2004
3Interferon alpha-2 (Roferon-A)FDA Link
05/2007 - 03/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 11/2021
2SteroidsIBA
11/2021 - 01/2021
2Monoclonal AntibodiesIBA
01/2021 - 07/2008
2Troponin IIBA
01/2021 - 01/2019
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021 - 01/2021
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020 - 01/2016
2Imatinib Mesylate (Gleevec)FDA Link
11/2019 - 09/2013
2pazopanibFDA Link
03/2019 - 10/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2018 - 01/2016
2Interleukin-15 (Interleukin 15)IBA
11/2018 - 11/2009
2Formaldehyde (Formol)FDA Link
10/2018 - 01/2018
2ParaffinIBA
10/2018 - 01/2018
2GemcitabineFDA Link
09/2017 - 09/2006
2Mitogen-Activated Protein KinasesIBA
01/2016 - 03/2007
2Phosphotransferases (Kinase)IBA
04/2014 - 03/2007
2PlatinumIBA
04/2014 - 12/2006
2interleukin-21 (interleukin 21)IBA
01/2014 - 11/2009
2Bevacizumab (Avastin)FDA Link
11/2013 - 03/2010
2AndrogensIBA
03/2013 - 12/2006
2Prostate-Specific Antigen (Semenogelase)IBA
09/2011 - 12/2006
2Coloring Agents (Dyes)IBA
11/2008 - 01/2007
2EpitopesIBA
07/2008 - 01/2006
2Biological ProductsIBA
09/2007 - 01/2003
2DNA (Deoxyribonucleic Acid)IBA
12/2006 - 09/2002
2Interferon-alpha (Interferon Alfa)IBA
01/2003 - 09/2002
1tocilizumab (atlizumab)FDA Link
12/2021
1vedolizumabIBA
11/2021
14- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
11/2021
1Infliximab (Remicade)FDA Link
11/2021
1ThrombinFDA Link
11/2021
1Propranolol (Inderal)FDA LinkGeneric
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1TroponinIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021

Therapy/Procedure

50Therapeutics
01/2022 - 01/2003
25Immunotherapy
01/2021 - 09/2005
6Drug Therapy (Chemotherapy)
03/2013 - 12/2006
4Radiotherapy
05/2011 - 03/2007
2Precision Medicine
01/2021 - 01/2019
2Aftercare (After-Treatment)
01/2016 - 11/2014
2Injections
11/2010 - 03/2004
2Biological Therapy
09/2007 - 03/2004
2Drug Tapering
03/2007 - 09/2006